Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Sarah Avent

- PMLiVE

Agility in medical affairs: responding to rapid market and regulatory shifts

By Maurice Leonard

- PMLiVE

Optimised therapy to improve outcomes for heart attack and stroke patients

Personalising therapy promises to revolutionise the treatment of thrombosis

- PMLiVE

The new era of medical affairs: busting myths and supercharging strategic value

‘MA creates the scientific conditions for long-term, trustworthy commercial success’

- PMLiVE

Does real-world use of AI in systematic literature reviews result in time and cost savings?

By Manca Povsic and Emma Griffiths

Amiculum

- PMLiVE

J&J’s Tremfya improves symptoms of psoriatic arthritis including joint damage

Psoriatic arthritis can develop in up to 30% of people with psoriasis

- PMLiVE

Novartis announces plans for new US manufacturing hub

The US hub is expected to create 700 new jobs by 2030

- PMLiVE

The most overlooked KPI in business? Joy

By Neha Desai Sulliman

- PMLiVE

Reimagining pharma CX: three game-changing products driving human-centric innovation

By Rachael McLoughlin

- PMLiVE

When populism meets public health: trust under siege

By Eleanor Read

- PMLiVE

The building of Aspire Pharma and values

By Carolyne Malizia

- PMLiVE

How DataGateway unified oncology data for real-world insights & market intelligence

Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.

Inizio

- PMLiVE

Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.

Inizio

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links